http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112021003335-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f4a900d2d9308385d00e4c55a0114bd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7120f7e027d375d909b703fa264223d |
| publicationDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112021003335-A2 |
| titleOfInvention | method to induce glandular selective pharmacoablation of the prostate with preservation of nerves and preservation of sexual function |
| abstract | method for inducing selective glandular pharmacoablation of the prostate with preservation of nerves and preservation of sexual function. methods of selective glandular drug ablation using compositions containing small peptide-based compounds and a pharmaceutically acceptable carrier are disclosed. methods for selectively destroying prostate gland overgrowth substantially or completely preserve major nervous, stromal, vascular, and connective tissue, urethral musculature, and structural elements in close structural proximity to ablation foci. |
| priorityDate | 2018-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.